Document Detail


Single agent chemotherapy for head and neck cancers. The murine subrenal capsule assay.
MedLine Citation:
PMID:  6314954     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The murine subrenal capsule assay was used to determine chemotherapeutic sensitivities of metastatic, primary, or recurrent head and neck cancers. Tumor fragments (1 cu mm) were implanted under the renal capsule of 2- to 4-month-old normal female C57 BL/6 X DBA/2 F1 hybrid mice. Xenografts included 20 squamous cell carcinomas (SCCs), one mucoepidermoid carcinoma, one adenoid cystic carcinoma, and two melanomas. Groups of tumor-bearing mice were treated with chemotherapy daily for five days. Sensitivities of the tumor were assessed on day 6 by comparison of final implant size with initial implant size. Significant oncolytic activity was detected against 16 of 24 tumors (14 of 20 SCCs and both melanomas). Correlations between the in vivo assay and clinical studies are needed to determine its predictive value.
Authors:
K J McCormick; W R Panje; S Seltzer; R H Merrick
Related Documents :
9974074 - Pigmented villonodular synovitis of the temporomandibular joint: diagnostic imaging and...
8818504 - Exfoliated malignant cells in glove and instrument washings following head and neck sur...
23258564 - Stability of the recombinant anti‑erbb2 scfv‑fc‑interleukin‑2 fusion protein an...
7615354 - Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and...
17193824 - Gastrointestinal stromal tumors: differential diagnosis.
23029544 - Modulators of sensitivity and resistance to inhibition of pi3k identified in a pharmaco...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of otolaryngology (Chicago, Ill. : 1960)     Volume:  109     ISSN:  0003-9977     ISO Abbreviation:  Arch Otolaryngol     Publication Date:  1983 Nov 
Date Detail:
Created Date:  1983-12-17     Completed Date:  1983-12-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0376526     Medline TA:  Arch Otolaryngol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  715-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / therapeutic use*
Carcinoma / drug therapy
Carcinoma, Adenoid Cystic / drug therapy
Carcinoma, Squamous Cell / drug therapy
Cyclophosphamide / therapeutic use
Drug Resistance
Female
Head and Neck Neoplasms / drug therapy*
Humans
Kidney / surgery
Melanoma / drug therapy
Methotrexate / therapeutic use
Mice
Neoplasm Transplantation
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 50-18-0/Cyclophosphamide; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Colony-forming assay of human salivary gland tumors. Applications for chemosensitivity and histogene...
Next Document:  Epstein-Barr virus antibody titers in cancer of the head and neck.